Baseline and follow-up study sample demographic, laboratory and clinical characteristics.

Mean ± SD, otherwise indicated; HAND: HIV-associated neurocognitive disorder; ANI: Asymptomatic neurocognitive impairment; MND; Mild Neurocognitive Disorder; HAD: HIV-associated dementia1No new AIDS defining Illness, 1 single case had a CD4 dropping below 200 cp/mL288.7% did not change their cART between baseline and follow-up. There was a significant difference between those who changed cART and those who did not in their plasma viral load suppression at follow-up: changed and detectable = 33.3%; did not change and detectable = 9.8%; p3Log10 Plasma HIV RNA were compared using Wilcoxon Signed Rank Test4Pearson correlation between baseline and follow-up Log(n) is. 73.Baseline and follow-up study sample demographic, laboratory and clinical characteristics.